OROKEN Side Effects

5932861-9 | Arthralgia, Insomnia
on Oct 23, 2008 Male patient from FRANCE , 72 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), sepsis (What is sepsis?) and was treated with Oroken (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, insomnia. Oroken dosage: . During the same period patient was treated with DOLIPRANE (View Doliprane Review and Doliprane Label ), KALEORID (View Kaleorid Review and Kaleorid Label ), CRESTOR (View Crestor Review and Crestor Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), OFLOCET (View Oflocet Review and Oflocet Label ), FLUDEX (View Fludex Review and Fludex Label ).

5832179-9 | Arthralgia, Insomnia
Patient was taking Oroken (View Usage). Patient had the following side effects: arthralgia, insomnia on Jul 29, 2008 from FRANCE Additional patient health information: Male patient , 73 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), sepsis (What is sepsis?) and. Oroken dosage: . During the same period patient was treated with POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FLUDEX (View Fludex Review and Fludex Label ), CRESTOR (View Crestor Review and Crestor Label ), OFLOCET (View Oflocet Review and Oflocet Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ).

5825704-5 | Renal Failure Acute
Adverse event was reported on Jan 07, 2008 by a Female patient taking Oroken (View Usage) (Dosage: ) was diagnosed with diarrhoea, ocular icterus and. Location: JAPAN , child 3 years of age, After Oroken was administered, patient had the following side effects: renal failure acute. During the same period patient was treated with CO TRIMOXAZOLE (View Co-trimoxazole Review and Co-trimoxazole Label ). Patient was hospitalized.

5819508-7 | Nausea, Nonspecific Reaction
on Jul 14, 2008 Female patient from JAPAN , 75 years of age, was treated with Oroken (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?), nonspecific reaction. Oroken dosage: . During the same period patient was treated with DOMPERIDONE (View Domperidone Review and Domperidone Label ), COZAAR (View Cozaar Review and Cozaar Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), TOPALGIC (200 Mg Daily) (View Topalgic Review and Topalgic Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.


5777746-6 | Clostridium Difficile Colitis, Septic Shock, Staphylococcal Infection
on Jun 12, 2008 Female patient from FRANCE , 76 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Oroken (View Usage). Patient had the following side effects: clostridium difficile colitis, septic shock, staphylococcal infection (What is staphylococcal infection?). Oroken dosage: . Patient was hospitalized.

5753333-0 | Dermatitis Bullous, Photosensitivity Reaction
Patient was taking Oroken (View Usage). After Oroken was administered, patient had the following side effects: dermatitis bullous, photosensitivity reaction on May 23, 2008 from JAPAN Additional patient health information: Male patient , 59 years of age, was diagnosed with bronchitis (What is bronchitis?) and. Oroken dosage: 400 Mg /daily. During the same period patient was treated with RULID (View Rulid Review and Rulid Label ). Patient was hospitalized.

5752108-6 | International Normalised Ratio Increased
Adverse event was reported on May 22, 2008 by a Female patient taking Oroken (View Usage) (Dosage: ) was diagnosed with pyelonephritis and. Location: JAPAN , 76 years of age, Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), DIACEREIN (View Diacerein Review and Diacerein Label ), LESCOL (View Lescol Review and Lescol Label ), NEBIVOLOL HCL (View Nebivolol Hcl Review and Nebivolol Hcl Label ), PREVISCAN (View Previscan Review and Previscan Label ), INNOHEP (View Innohep Review and Innohep Label ).

5747525-4 | Angioedema
on May 16, 2008 Female patient from FRANCE , 33 years of age, was treated with Oroken (View Usage). Patient had the following side effects: angioedema. Oroken dosage: . Patient was hospitalized.

5739384-0 | Haemoptysis, International Normalised Ratio Increased, Overdose
on May 06, 2008 Female patient from JAPAN , 76 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Oroken (View Usage). After Oroken was administered, patient had the following side effects: haemoptysis, international normalised ratio increased, overdose. Oroken dosage: . During the same period patient was treated with HYPERIUM (View Hyperium Review and Hyperium Label ), MEDIATENSYL (View Mediatensyl Review and Mediatensyl Label ), DIFFU K (View Diffu K Review and Diffu K Label ), PREVISCAN (10 Mg Daily) (View Previscan Review and Previscan Label ), FLUDEX (View Fludex Review and Fludex Label ), DAONIL (View Daonil Review and Daonil Label ), MODOPAR (View Modopar Review and Modopar Label ). Patient was hospitalized.

5728992-9 | Haemoptysis, International Normalised Ratio Increased
Patient was taking Oroken (View Usage). Patient experienced the following unwanted or unexpected effects: haemoptysis, international normalised ratio increased on Apr 25, 2008 from JAPAN Additional patient health information: Female patient , 76 years of age, was diagnosed with bronchitis (What is bronchitis?) and. Oroken dosage: . During the same period patient was treated with HYPERIUM (View Hyperium Review and Hyperium Label ), MEDIATENSYL (View Mediatensyl Review and Mediatensyl Label ), DIFFU K (View Diffu K Review and Diffu K Label ), PREVISCAN (10 Mg Daily) (View Previscan Review and Previscan Label ), FLUDEX (View Fludex Review and Fludex Label ), DAONIL (View Daonil Review and Daonil Label ), MODOPAR (View Modopar Review and Modopar Label ). Patient was hospitalized.

5721516-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Cholestasis
Adverse event was reported on Apr 18, 2008 by a Female patient taking Oroken (View Usage) (Dosage: ) . Location: JAPAN , 30 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholestasis. During the same period patient was treated with TARDYFERON (View Tardyferon Review and Tardyferon Label ). Patient was hospitalized.

5657415-3 | Dyspnoea, Fibrin D Dimer Increased, Nausea
on Mar 03, 2008 Female patient from JAPAN , 55 years of age, was diagnosed with vaginal infection and was treated with Oroken (View Usage). After Oroken was administered, patient had the following side effects: dyspnoea, fibrin d dimer increased, nausea (What is nausea?). Oroken dosage: 400mg Daily. Patient was hospitalized.

5626485-0 | Renal Failure Acute
on Feb 12, 2008 Female patient from JAPAN , child 3 years of age, was diagnosed with diarrhoea, ocular icterus and was treated with Oroken (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Oroken dosage: . During the same period patient was treated with CO TRIMOXAZOLE (View Co-trimoxazole Review and Co-trimoxazole Label ). Patient was hospitalized.

5579460-9 | Hepatitis A, Renal Failure Acute, Renal Tubular Necrosis
Patient was taking Oroken (View Usage). Patient had the following side effects: hepatitis a (What is hepatitis a?), renal failure acute, renal tubular necrosis on Dec 21, 2007 from JAPAN Additional patient health information: Female patient , child 3 years of age, was diagnosed with diarrhoea, ocular icterus and. Oroken dosage: . During the same period patient was treated with COTRIM (View Cotrim Review and Cotrim Label ). Patient was hospitalized.

5546801-8 | Pallor, Paraesthesia Oral, Syncope
Adverse event was reported on Dec 07, 2007 by a Male patient taking Oroken (View Usage) (Dosage: ) . Location: FRANCE , child 4 years of age, After Oroken was administered, patient had the following side effects: pallor, paraesthesia oral, syncope. Patient was hospitalized.

5509804-5 | Telangiectasia, Vascular Purpura
on Nov 02, 2007 Male patient from FRANCE , 73 years of age, was diagnosed with prostatitis, herpes virus infection and was treated with Oroken (View Usage). Patient experienced the following unwanted or unexpected effects: telangiectasia, vascular purpura. Oroken dosage: . During the same period patient was treated with ZELITREX (View Zelitrex Review and Zelitrex Label ), HYTACAND (View Hytacand Review and Hytacand Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), VASTIN (View Vastin Review and Vastin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PREVISCAN (Not Provided) (View Previscan Review and Previscan Label ), CIFLOX (View Ciflox Review and Ciflox Label ), BUFLOMEDIL (View Buflomedil Review and Buflomedil Label ). Patient was hospitalized.

5502693-4 | Angioedema, Dry Mouth, Erythema
on Oct 23, 2007 Female patient from FRANCE , 77 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Oroken (View Usage). Patient had the following side effects: angioedema, dry mouth, erythema. Oroken dosage: . During the same period patient was treated with FURADANTIN (View Furadantin Review and Furadantin Label ).

5481230-7 | Cardiogenic Shock, Cytolytic Hepatitis, Hepatic Failure, Intentional Overdose, Pancreatitis, Renal Failure
Patient was taking Oroken (View Usage). After Oroken was administered, patient had the following side effects: cardiogenic shock, cytolytic hepatitis, hepatic failure, intentional overdose, pancreatitis, renal failure on Oct 05, 2007 from JAPAN Additional patient health information: Female patient , 23 years of age, . Oroken dosage: . During the same period patient was treated with ZOPICLONE (View Zopiclone Review and Zopiclone Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ). Patient was hospitalized.

5466962-9 | Condition Aggravated, Tendonitis
Adverse event was reported on Sep 20, 2007 by a Female patient taking Oroken (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: JAPAN , 46 years of age, Patient experienced the following unwanted or unexpected effects: condition aggravated, tendonitis.

5401760-3 | Asthenia, Clostridium Difficile Colitis
on Jul 19, 2007 Male patient from JAPAN , 82 years of age, was diagnosed with renal colic, infection (What is infection?) and was treated with Oroken (View Usage). Patient had the following side effects: asthenia, clostridium difficile colitis. Oroken dosage: 200 Mg Daily. During the same period patient was treated with NOROXIN (400 Mg Daily) (View Noroxin Review and Noroxin Label ), ROCEPHIN (1 G Daily) (View Rocephin Review and Rocephin Label ), ORELOX (200 Mg Daily) (View Orelox Review and Orelox Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), CORDARONE (View Cordarone Review and Cordarone Label ), ASPEGIC 325 (View Aspegic 325 Review and Aspegic 325 Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), SPASFON (View Spasfon Review and Spasfon Label ). Patient was hospitalized.

5386310-2 | Abortion Spontaneous
on Jul 06, 2007 Female patient from JAPAN , 25 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Oroken (View Usage). After Oroken was administered, patient had the following side effects: abortion spontaneous. Oroken dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), THIOCOLCHICOSIDE (View Thiocolchicoside Review and Thiocolchicoside Label ), PARACETAMOL (3 G Daily) (View Paracetamol Review and Paracetamol Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), ATHYMIL (View Athymil Review and Athymil Label ). Patient was hospitalized.

5358605-X | Angioedema, Malaise
Patient was taking Oroken (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, malaise on Jun 13, 2007 from FRANCE Additional patient health information: Male patient , child 4 years of age, . Oroken dosage: . Patient was hospitalized.

5053138-2 | Cheilitis, Conjunctival Disorder, Dermatitis Bullous, Photosensitivity Reaction, Pruritus, Purpura, Pyrexia
Adverse event was reported on Jun 30, 2006 by a Female patient taking Oroken (View Usage) (Dosage: Oral) was diagnosed with abdominal pain (What is abdominal pain?), pyrexia and. Location: FRANCE , child 8 years of age, Patient had the following side effects: cheilitis, conjunctival disorder, dermatitis bullous, photosensitivity reaction, pruritus, purpura, pyrexia. During the same period patient was treated with BACTRIM (Oral) (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

4714505-7 | Platelet Count Increased, Thrombocythaemia
on Jul 04, 2005 Male patient from , 64 years of age, was diagnosed with superinfection lung and was treated with Oroken (View Usage). After Oroken was administered, patient had the following side effects: platelet count increased, thrombocythaemia. Oroken dosage: . During the same period patient was treated with CLAFORAN (View Claforan Review and Claforan Label ), OFLOCET (View Oflocet Review and Oflocet Label ), NIZORAL (View Nizoral Review and Nizoral Label ), EUPHYLLINE (View Euphylline Review and Euphylline Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ). Patient was hospitalized.